SCHEMBL1116271

SCHEMBL1116271

Cc1noc(C)c1-c1ccc(C=O)o1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 5/20 0.53
▸ ERN1 O75460 5/20 0.46
▸ BRD2 P25440 2/20 0.43
▸ KDM4E B2RXH2 6/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ LMNA P02545 2/20 0.41
▸ GAA P10253 1/20 0.41
▸ CYP2E1 P05181 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2B6 P20813 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ MAPT P10636 3/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ PKM P14618 1/20 0.40
▸ POLB P06746 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3101765 0.73 ERN1 (0.56) BRD4ERN1BRD2ALDH1A1MEN1
SCHEMBL1116165 0.72 CA2 (0.38) BRD4BRD2KDM4EALDH1A1MAPT
SCHEMBL1116166 0.72 CA2 (0.38) BRD4BRD2KDM4EALDH1A1MAPT
SCHEMBL3039493 0.72 ALDH1A1 (0.50) KDM4EALDH1A1LMNAGAACYP2E1
SCHEMBL1115919 0.72 CLK1 (0.41) BRD4BRD2KDM4EALDH1A1LMNA
SCHEMBL1115917 0.72 CLK1 (0.41) BRD4BRD2KDM4EALDH1A1LMNA
SCHEMBL28747775 0.71 AR (0.49) BRD4ERN1BRD2KDM4EALDH1A1
SCHEMBL6656195 0.71 ALDH1A1 (0.61) KDM4EALDH1A1LMNAGAACYP2E1
SCHEMBL6859308 0.71 IDH1 (0.41) BRD4BRD2KDM4EALDH1A1LMNA
SCHEMBL2323855 0.70 ALDH1A1 (0.44) KDM4EALDH1A1LMNAGAACYP2E1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011015646-A2 FURAN-IMIDAZOLONE DERIVATIVES, FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS NOSCIRA, S.A. (ES) 2011-02-10 — — WO disclosed
WO-2011015646-A2 FURAN-IMIDAZOLONE DERIVATIVES, FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS NOSCIRA, S.A. (ES) 2011-02-10 — — WO disclosed
EP-2281824-A1 Furan-imidazolone derivatives, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders NOSCIRA, S.A. (ES) 2011-02-09 — — EP disclosed
EP-2281824-A1 Furan-imidazolone derivatives, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders NOSCIRA, S.A. (ES) 2011-02-09 — — EP disclosed
Send feedback